70 results
Page 2 of 4
8-K
EX-99.1
uurn9kqy bnppk
16 Jun 22
Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK
8:35am
8-K
EX-99.1
pqnnk3208j7txq6vho
26 May 22
Moleculin Commences Dosing in Healthy Volunteers in Phase 1a Clinical Trial of WP1122 for the Treatment of COVID-19
8:35am
8-K
EX-99.1
hma67lgw7 ao1trot
12 May 22
Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update
8:35am
8-K
EX-99.1
5mpf2zqofvz ny7jf
10 May 22
Regulation FD Disclosure
8:35am
8-K
EX-99.1
81ovz00tfrevmc9mel52
5 May 22
Regulation FD Disclosure
8:15am
8-K
EX-99.1
ksoyausq7lhi9 dwtz8
12 Nov 21
Moleculin Reports Third Quarter 2021 Financial Results and Provides Programs Update
7:30am
8-K
EX-99.1
wmm mq8s9eidkln3x
8 Feb 21
Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases
7:29am
424B5
skz0t
4 Feb 21
Prospectus supplement for primary offering
4:01pm
424B5
2k04m89ocudbz82 65yl
2 Feb 21
Prospectus supplement for primary offering
4:29pm